Ahmed Idbaih

37PUBLICATIONS
146CO-AUTHORS
Cancer geneticsPredictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jul 15, 2026
BRAF-MEK inhibition in a giant BRAF-mutant Rathke cleft cyst: Diagnostic challenges and clinical implications for BRAF testing.

|Mar 09, 2026
Prognostic factors in adult patients with medulloblastoma.

Ytel Garcilazo-Reyes, Pierre Dal Col, Franck Bielle

|Feb 02, 2026
18F-DOPA-PET and Advanced MRI Improve Treatment Response Assessment in IDH1/2-Mutant Gliomas Treated with IDH Inhibitors.

Diego Prost, Lucia Nichelli, Laura Rozenblum

|Mar 20, 2025
Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 study.

Linda Dirven, Abigirl Machingura, Martin J van den Bent

|Nov 27, 2024
Clinical Applications of Antisense Oligonucleotides in Cancer: A Focus on Glioblastoma.

Alexandre Khuu, Maïté Verreault, Philippe Colin

|Oct 21, 2024
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort.

Domique Figarella-Branger, Carole Colin, Karima Mokhtari

Pageof 7

Frequent Collaborators

8 joint publications

Giuseppe Lombardi

7 joint publications

Franck Bielle

5 joint publications

Mehdi Touat

5 joint publications

Michael Weller